VBIV Annual EBITDA
-$82.78 M
+$23.24 M+21.92%
31 December 2023
Summary:
As of February 5, 2025, VBIV annual earnings before interest, taxes, depreciation & amortization is -$82.78 million, with the most recent change of +$23.24 million (+21.92%) on December 31, 2023. During the last 3 years, it has fallen by -$41.52 million (-100.65%).VBIV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Quarterly EBITDA
-$15.39 M
-$17.92 M-708.90%
31 March 2024
Summary:
As of February 5, 2025, VBIV quarterly earnings before interest, taxes, depreciation & amortization is -$15.39 million, with the most recent change of -$17.92 million (-708.90%) on March 31, 2024. Over the past year, it has increased by +$26.72 million (+63.45%).VBIV Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV TTM EBITDA
-$72.86 M
+$9.92 M+11.98%
31 March 2024
Summary:
As of February 5, 2025, VBIV TTM earnings before interest, taxes, depreciation & amortization is -$72.86 million, with the most recent change of +$9.92 million (+11.98%) on March 31, 2024. Over the past year, it has increased by +$36.74 million (+33.52%).VBIV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.9% | +63.5% | +33.5% |
| 3 y3 years | -100.7% | +18.0% | +31.3% |
| 5 y5 years | -38.4% | +18.0% | +31.3% |
VBIV EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | <-9999.0% | -708.9% | <-9999.0% |
VBI Vaccines EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$15.39 M(-708.9%) | -$72.86 M(-12.0%) |
| Dec 2023 | -$82.78 M(-21.9%) | $2.53 M(-114.1%) | -$82.78 M(-20.5%) |
| Sept 2023 | - | -$17.89 M(-57.5%) | -$104.08 M(-5.0%) |
| June 2023 | - | -$42.11 M(+66.4%) | -$109.60 M(-1.8%) |
| Mar 2023 | - | -$25.31 M(+34.9%) | -$111.57 M(+5.2%) |
| Dec 2022 | -$106.02 M(+68.8%) | -$18.77 M(-19.8%) | -$106.02 M(+1.5%) |
| Sept 2022 | - | -$23.41 M(-46.9%) | -$104.45 M(+9.6%) |
| June 2022 | - | -$44.08 M(+123.0%) | -$95.33 M(+41.5%) |
| Mar 2022 | - | -$19.76 M(+14.9%) | -$67.38 M(+7.3%) |
| Dec 2021 | -$62.81 M(+52.3%) | -$17.20 M(+20.3%) | -$62.81 M(+5.3%) |
| Sept 2021 | - | -$14.30 M(-11.3%) | -$59.66 M(+4.6%) |
| June 2021 | - | -$16.12 M(+6.0%) | -$57.05 M(+15.9%) |
| Mar 2021 | - | -$15.20 M(+8.3%) | -$49.22 M(+19.3%) |
| Dec 2020 | -$41.26 M(-18.4%) | -$14.04 M(+20.1%) | -$41.26 M(+11.7%) |
| Sept 2020 | - | -$11.69 M(+41.1%) | -$36.95 M(-8.2%) |
| June 2020 | - | -$8.29 M(+14.5%) | -$40.25 M(-8.7%) |
| Mar 2020 | - | -$7.24 M(-25.6%) | -$44.11 M(-12.8%) |
| Dec 2019 | -$50.58 M(-15.4%) | -$9.73 M(-35.1%) | -$50.58 M(-14.4%) |
| Sept 2019 | - | -$15.00 M(+23.5%) | -$59.12 M(+1.0%) |
| June 2019 | - | -$12.14 M(-11.4%) | -$58.52 M(-5.9%) |
| Mar 2019 | - | -$13.71 M(-25.0%) | -$62.19 M(+4.0%) |
| Dec 2018 | -$59.80 M(+67.7%) | -$18.27 M(+26.9%) | -$59.81 M(+14.8%) |
| Sept 2018 | - | -$14.40 M(-8.9%) | -$52.12 M(+11.9%) |
| June 2018 | - | -$15.81 M(+39.6%) | -$46.57 M(+19.9%) |
| Mar 2018 | - | -$11.33 M(+7.1%) | -$38.83 M(+8.8%) |
| Dec 2017 | -$35.66 M(+48.3%) | -$10.58 M(+19.6%) | -$35.70 M(+2.3%) |
| Sept 2017 | - | -$8.85 M(+9.5%) | -$34.91 M(+5.3%) |
| June 2017 | - | -$8.08 M(-1.4%) | -$33.14 M(+5.8%) |
| Mar 2017 | - | -$8.19 M(-16.3%) | -$31.33 M(+30.2%) |
| Dec 2016 | -$24.05 M(-2.7%) | -$9.79 M(+38.3%) | -$24.05 M(-24.1%) |
| Sept 2016 | - | -$7.08 M(+13.0%) | -$31.67 M(+7.5%) |
| June 2016 | - | -$6.26 M(+579.5%) | -$29.46 M(+22.1%) |
| Mar 2016 | - | -$922.00 K(-94.7%) | -$24.12 M(+1.2%) |
| Dec 2015 | -$24.73 M(+501.1%) | -$17.41 M(+257.6%) | -$23.84 M(+204.8%) |
| Sept 2015 | - | -$4.87 M(+426.3%) | -$7.82 M(+87.1%) |
| June 2015 | - | -$924.90 K(+45.5%) | -$4.18 M(-1.5%) |
| Mar 2015 | - | -$635.70 K(-54.4%) | -$4.24 M(-17.7%) |
| Mar 2015 | -$4.11 M(-21.8%) | - | - |
| Dec 2014 | - | -$1.39 M(+13.6%) | -$5.15 M(-10.7%) |
| Sept 2014 | - | -$1.23 M(+24.3%) | -$5.77 M(+4.0%) |
| June 2014 | - | -$986.80 K(-36.2%) | -$5.55 M(+4.7%) |
| Mar 2014 | -$5.26 M(-28.4%) | -$1.55 M(-23.1%) | -$5.30 M(+19.2%) |
| Dec 2013 | - | -$2.01 M(+99.6%) | -$4.45 M(+16.7%) |
| Sept 2013 | - | -$1.01 M(+36.6%) | -$3.81 M(-34.2%) |
| June 2013 | - | -$737.30 K(+6.6%) | -$5.79 M(-20.9%) |
| Mar 2013 | -$7.34 M(-46.0%) | -$691.40 K(-49.6%) | -$7.32 M(-27.6%) |
| Dec 2012 | - | -$1.37 M(-54.1%) | -$10.11 M(-12.7%) |
| Sept 2012 | - | -$2.99 M(+31.7%) | -$11.58 M(-3.3%) |
| June 2012 | - | -$2.27 M(-34.8%) | -$11.98 M(-12.8%) |
| Mar 2012 | -$13.59 M(-46.3%) | -$3.48 M(+22.4%) | -$13.74 M(-52.0%) |
| Dec 2011 | - | -$2.84 M(-16.1%) | -$28.64 M(+3.4%) |
| Sept 2011 | - | -$3.39 M(-16.0%) | -$27.69 M(-0.6%) |
| June 2011 | - | -$4.03 M(-78.0%) | -$27.86 M(+10.8%) |
| Mar 2011 | -$25.33 M | -$18.38 M(+870.1%) | -$25.15 M(+250.9%) |
| Dec 2010 | - | -$1.89 M(-46.7%) | -$7.17 M(+32.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2010 | - | -$3.55 M(+168.9%) | -$5.43 M(+177.3%) |
| June 2010 | - | -$1.32 M(+232.9%) | -$1.96 M(+172.0%) |
| Mar 2010 | -$730.60 K(+183.6%) | -$396.90 K(+151.0%) | -$719.80 K(+85.2%) |
| Dec 2009 | - | -$158.10 K(+93.8%) | -$388.70 K(+31.9%) |
| Sept 2009 | - | -$81.60 K(-1.9%) | -$294.80 K(-2.4%) |
| June 2009 | - | -$83.20 K(+26.4%) | -$302.00 K(+8.2%) |
| Mar 2009 | -$257.60 K(-55.2%) | -$65.80 K(+2.5%) | -$279.10 K(-17.8%) |
| Dec 2008 | - | -$64.20 K(-27.7%) | -$339.50 K(-22.8%) |
| Sept 2008 | - | -$88.80 K(+47.3%) | -$439.50 K(-20.2%) |
| June 2008 | - | -$60.30 K(-52.2%) | -$550.70 K(-3.2%) |
| Mar 2008 | -$575.10 K(+55.1%) | -$126.20 K(-23.1%) | -$568.80 K(-4.4%) |
| Dec 2007 | - | -$164.20 K(-17.9%) | -$595.00 K(+20.7%) |
| Sept 2007 | - | -$200.00 K(+155.1%) | -$493.10 K(+27.8%) |
| June 2007 | - | -$78.40 K(-48.6%) | -$385.90 K(+2.2%) |
| Mar 2007 | -$370.80 K(-10.4%) | -$152.40 K(+144.6%) | -$377.60 K(-26.6%) |
| Dec 2006 | - | -$62.30 K(-32.9%) | -$514.10 K(+5.5%) |
| Sept 2006 | - | -$92.80 K(+32.4%) | -$487.40 K(+10.3%) |
| June 2006 | - | -$70.10 K(-75.7%) | -$441.80 K(+6.9%) |
| Mar 2006 | -$414.00 K(+212.9%) | -$288.90 K(+711.5%) | -$413.30 K(+121.5%) |
| Dec 2005 | - | -$35.60 K(-24.6%) | -$186.60 K(+11.3%) |
| Sept 2005 | - | -$47.20 K(+13.5%) | -$167.70 K(+18.4%) |
| June 2005 | - | -$41.60 K(-33.1%) | -$141.60 K(+16.8%) |
| Mar 2005 | -$132.30 K(+1.0%) | -$62.20 K(+272.5%) | -$121.20 K(+47.6%) |
| Dec 2004 | - | -$16.70 K(-20.9%) | -$82.10 K(-26.1%) |
| Sept 2004 | - | -$21.10 K(-0.5%) | -$111.10 K(-7.5%) |
| June 2004 | - | -$21.20 K(-8.2%) | -$120.10 K(-6.4%) |
| Mar 2004 | -$131.00 K(+62.1%) | -$23.10 K(-49.5%) | -$128.30 K(-10.7%) |
| Dec 2003 | - | -$45.70 K(+51.8%) | -$143.60 K(+34.3%) |
| Sept 2003 | - | -$30.10 K(+2.4%) | -$106.90 K(+11.6%) |
| June 2003 | - | -$29.40 K(-23.4%) | -$95.80 K(+24.4%) |
| Mar 2003 | -$80.80 K(+15.8%) | -$38.40 K(+326.7%) | -$77.00 K(+12.2%) |
| Dec 2002 | - | -$9000.00(-52.6%) | -$68.60 K(-3.1%) |
| Sept 2002 | - | -$19.00 K(+79.2%) | -$70.80 K(+13.6%) |
| June 2002 | - | -$10.60 K(-64.7%) | -$62.30 K(-11.9%) |
| Mar 2002 | -$69.80 K(<-9900.0%) | -$30.00 K(+167.9%) | -$70.70 K(-355.2%) |
| Dec 2001 | - | -$11.20 K(+6.7%) | $27.70 K(+65.9%) |
| Sept 2001 | - | -$10.50 K(-44.7%) | $16.70 K(+317.5%) |
| June 2001 | - | -$19.00 K(-127.8%) | $4000.00(-95.6%) |
| Mar 2001 | $0.00(-100.0%) | $68.40 K(-408.1%) | $90.50 K(+305.8%) |
| Dec 2000 | - | -$22.20 K(-4.3%) | $22.30 K(-80.4%) |
| Sept 2000 | - | -$23.20 K(-134.4%) | $113.50 K(-17.0%) |
| June 2000 | - | $67.50 K(>+9900.0%) | $136.70 K(-0.2%) |
| Mar 2000 | -$68.80 K(-48.1%) | $200.00(-99.7%) | $137.00 K(+3086.0%) |
| Dec 1999 | - | $69.00 K(>+9900.0%) | $4300.00(+1333.3%) |
| Sept 1999 | - | $0.00(-100.0%) | $300.00(0.0%) |
| June 1999 | - | $67.80 K(-151.2%) | $300.00(-50.0%) |
| Mar 1999 | -$132.50 K(+88.2%) | -$132.50 K(-303.8%) | $600.00(-99.0%) |
| Dec 1998 | - | $65.00 K(>+9900.0%) | $62.70 K(-7.2%) |
| Sept 1998 | - | $0.00(-100.0%) | $67.60 K(-51.7%) |
| June 1998 | - | $68.10 K(-196.7%) | $140.00 K(-3.0%) |
| Mar 1998 | -$70.40 K(-2.9%) | -$70.40 K(-200.7%) | $144.30 K(-32.8%) |
| Dec 1997 | - | $69.90 K(-3.5%) | $214.70 K(+48.3%) |
| Sept 1997 | - | $72.40 K(0.0%) | $144.80 K(+100.0%) |
| June 1997 | - | $72.40 K | $72.40 K |
| Mar 1997 | -$72.50 K | - | - |
FAQ
- What is VBI Vaccines annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for VBI Vaccines?
- What is VBI Vaccines annual EBITDA year-on-year change?
- What is VBI Vaccines quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for VBI Vaccines?
- What is VBI Vaccines quarterly EBITDA year-on-year change?
- What is VBI Vaccines TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for VBI Vaccines?
- What is VBI Vaccines TTM EBITDA year-on-year change?
What is VBI Vaccines annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of VBIV is -$82.78 M
What is the all time high annual EBITDA for VBI Vaccines?
VBI Vaccines all-time high annual earnings before interest, taxes, depreciation & amortization is $0.00
What is VBI Vaccines annual EBITDA year-on-year change?
Over the past year, VBIV annual earnings before interest, taxes, depreciation & amortization has changed by +$23.24 M (+21.92%)
What is VBI Vaccines quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of VBIV is -$15.39 M
What is the all time high quarterly EBITDA for VBI Vaccines?
VBI Vaccines all-time high quarterly earnings before interest, taxes, depreciation & amortization is $2.53 M
What is VBI Vaccines quarterly EBITDA year-on-year change?
Over the past year, VBIV quarterly earnings before interest, taxes, depreciation & amortization has changed by +$26.72 M (+63.45%)
What is VBI Vaccines TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of VBIV is -$72.86 M
What is the all time high TTM EBITDA for VBI Vaccines?
VBI Vaccines all-time high TTM earnings before interest, taxes, depreciation & amortization is $214.70 K
What is VBI Vaccines TTM EBITDA year-on-year change?
Over the past year, VBIV TTM earnings before interest, taxes, depreciation & amortization has changed by +$36.74 M (+33.52%)